April 6, 2017

Amicus Therapeutics Honors Fabry Disease Awareness Month and International Pompe Day

April 3, 2017

Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study

March 8, 2017

Amicus Therapeutics Launches Galafold™ (Migalastat) for Treatment of Fabry Disease in Italy